Publications

5808 Results

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trials [PMID21499862]

Authors
W Regine;KA Winter;R Abrams;H Safran;JP Hoffman;A Konski;A Benson;J Macdonald;TA Rich;CG Willett
Journal / Conference
Annals of Surgical Oncology 18(5):1319-1326
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
R9704

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

Authors
A Krishnan;MC Pasquini;B Logan;EA Stadtmauer;DH Vesole;E Alyea;AJ Antin;R Comenzo;S Goodman;P Hari;G Laport;MH Qazilbash;S Rowley;F Sahebi;G Somlo;DT Vogl;D Weisdorf;M Ewell;J Wu;NL Geller;MM Horowitz;S Giralt;DJ Maloney
Journal / Conference
Lancet Oncology 12(13):1195-1203
Year
2011
Research Committee(s)
Myeloma
PMID
PMID21962393
PMC
PMC3611089
Study Number(s)
CTN 0102

Postoperative adjuvant chemoradiation for gastric or gstroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101

Authors
C Fuchs;JE Tepper;D Niedzwiecki;D Hollis;HJ Mamon;R Swanson;DG Haller;T Dragovich;SR Alberts;GA Bjarnason;CG Willett;PC Enzinger;RM Goldberg;AP Venook;RJ Mayer
Journal / Conference
Journal of Clinical Oncology 29:2011 (suppl; abstr 4003); ASCO 2011 Meeting, oral presentation
Year
2011
Research Committee(s)
Gastrointestinal

Designing phase II trials of targeted cancer therapies

Authors
J Crowley
Journal / Conference
AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics (no abstract; invited presentation)
Year
2011
Research Committee(s)
Multiple sites

SWOG: Translational research initiative in a cooperative group setting

Authors
C Hoban;J Crowley;IM Thompson;D Hayes;C Ambrosone;G Hortobagyi;F Hirsch;D Gandara;L Rimsza;RI Fisher;LH Baker
Journal / Conference
NCI Translational Science Meeting 2011 (July 28-29, Washinton, DC), Abstract Book, p. 207 (oral presentation)
Year
2011
Research Committee(s)
Multiple sites

Designing a randomized trial to test an interaction of treatment and a continuous genomic assay

Authors
WE Barlow
Journal / Conference
International Society for Clinical Biostatistics 32nd Annual Meeting (Aug.21-25, Ottawa), invited oral presentation
Year
2011
Research Committee(s)
Breast
Study Number(s)
S1007

Comments on PFS as a primary endpoint in cancer clinical trials

Authors
JJ Crowley
Journal / Conference
International Association for the Study of Lung Cancer, 14th World Conference on Lung Cancer, invited oral presentation;
Year
2011
Research Committee(s)
Lung and Multiple sites

Phase II into III

Authors
M Redman;B Goldman;M Leblanc
Journal / Conference
Journal of Thoracic Oncology, 6(6):Supplement 2, abstract M11.4, p. S92; International Assn for the Study of Lung Cancer, 14th World Conf on Lung Cancer (July 3-7, Amsterdam), invited oral presentation
Year
2011
Research Committee(s)
Lung

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection

Authors
AJ Vickers;C Till;H Lilja;IM Thompson
Journal / Conference
Journal of the National Cancer Institute 103(6):462-469
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection [Commentary]

Authors
AJ Vickers
Journal / Conference
Journal of the Nationadld Cancer Institute 103(21):1635-1636
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217